Raloxifene plus ossein-hydroxyapatite compound versus raloxifene plus calcium carbonate to control bone loss in postmenopausal women: A randomized trial

  1. Pelayo, I.
  2. Haya, J.
  3. De La Cruz, J.J.
  4. Seco, C.
  5. Bugella, J.I.
  6. Diaz, J.L.
  7. Bajo, J.M.
  8. Repolles, M.
Journal:
Menopause

ISSN: 1072-3714

Year of publication: 2008

Volume: 15

Issue: 6

Pages: 1132-1138

Type: Article

DOI: 10.1097/GME.0B013E318170AF33 GOOGLE SCHOLAR

Sustainable development goals